8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Oct 21, 2025)

Filed October 21, 2025For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) has filed an 8-K report on October 21, 2025, disclosing its financial results for the quarter ended September 30, 2025. The press release, incorporated by reference, provides key operational and financial performance metrics. Investors should pay close attention to the details within this press release for a comprehensive understanding of the company's recent performance and its implications for future financial health and strategic direction. While the 8-K itself is brief and primarily serves to attach the press release, the substance of the filing lies within the attached document. This includes crucial information regarding revenue, profitability, earnings per share, and any significant business developments or outlooks provided by management. Investors are encouraged to review Exhibit 99.1 for a detailed breakdown of the quarterly performance and any forward-looking statements.

Key Highlights

  • 1Quest Diagnostics (DGX) filed an 8-K on October 21, 2025, to report Q3 2025 financial results.
  • 2The filing incorporates a press release (Exhibit 99.1) detailing the company's performance for the quarter ended September 30, 2025.
  • 3Investors can find key financial metrics and operational updates within the attached press release.
  • 4The 8-K itself is a notification filing, with detailed financial and operational information contained in Exhibit 99.1.
  • 5This filing is important for understanding recent business trends and management's commentary on the company's financial condition.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Quest Diagnostics' financial results for the quarter ended September 30, 2025, by attaching the relevant press release (Exhibit 99.1) as required by SEC regulations.

All the detailed financial information, including revenue, profitability, and other key performance indicators for the quarter ended September 30, 2025, can be found in Exhibit 99.1, which is the press release attached to this 8-K filing.

Forward-looking statements and any updated financial guidance from management are typically included in the press release (Exhibit 99.1) that is incorporated by reference in this 8-K filing. Investors should carefully review this document for such information.